| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 42 | 2024 | 624 | 10.240 |
Why?
|
| Inflammasomes | 12 | 2024 | 148 | 3.900 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 22 | 2022 | 232 | 2.990 |
Why?
|
| Myocytes, Cardiac | 31 | 2024 | 616 | 2.580 |
Why?
|
| Heart Atria | 12 | 2024 | 312 | 1.920 |
Why?
|
| Calcium | 22 | 2022 | 1096 | 1.830 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 8 | 2023 | 111 | 1.700 |
Why?
|
| Sarcoplasmic Reticulum | 16 | 2022 | 196 | 1.640 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 14 | 2022 | 168 | 1.610 |
Why?
|
| Anti-Arrhythmia Agents | 5 | 2022 | 218 | 1.470 |
Why?
|
| Arrhythmias, Cardiac | 11 | 2024 | 459 | 1.440 |
Why?
|
| Calcium Signaling | 14 | 2021 | 241 | 1.430 |
Why?
|
| Heart Rate | 7 | 2022 | 586 | 1.140 |
Why?
|
| Tachycardia, Ventricular | 7 | 2022 | 196 | 1.080 |
Why?
|
| Sinoatrial Node | 4 | 2024 | 24 | 1.060 |
Why?
|
| Atrial Remodeling | 2 | 2024 | 12 | 1.050 |
Why?
|
| Diet, High-Protein | 1 | 2024 | 5 | 0.910 |
Why?
|
| Animals | 58 | 2024 | 33749 | 0.840 |
Why?
|
| Signal Transduction | 8 | 2023 | 4489 | 0.840 |
Why?
|
| Sick Sinus Syndrome | 1 | 2022 | 12 | 0.840 |
Why?
|
| Interleukin-6 | 2 | 2024 | 393 | 0.810 |
Why?
|
| Myocardium | 10 | 2020 | 984 | 0.790 |
Why?
|
| Mice | 36 | 2024 | 17494 | 0.770 |
Why?
|
| Heart Failure | 12 | 2024 | 2127 | 0.740 |
Why?
|
| MicroRNAs | 4 | 2015 | 827 | 0.730 |
Why?
|
| Tacrolimus Binding Proteins | 4 | 2016 | 66 | 0.730 |
Why?
|
| Berberine | 3 | 2010 | 10 | 0.690 |
Why?
|
| Cyclic AMP Response Element Modulator | 4 | 2022 | 25 | 0.690 |
Why?
|
| Proteostasis | 1 | 2020 | 34 | 0.680 |
Why?
|
| Behcet Syndrome | 1 | 2019 | 16 | 0.650 |
Why?
|
| Calcium-Binding Proteins | 6 | 2019 | 327 | 0.650 |
Why?
|
| Disease Models, Animal | 21 | 2022 | 4271 | 0.640 |
Why?
|
| Isoproterenol | 5 | 2022 | 105 | 0.620 |
Why?
|
| Heart Conduction System | 4 | 2024 | 145 | 0.610 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2022 | 678 | 0.580 |
Why?
|
| Inflammation | 3 | 2022 | 1401 | 0.580 |
Why?
|
| Tetracaine | 1 | 2016 | 9 | 0.550 |
Why?
|
| Down-Regulation | 7 | 2023 | 697 | 0.540 |
Why?
|
| Hyperuricemia | 1 | 2016 | 36 | 0.530 |
Why?
|
| Uric Acid | 1 | 2016 | 94 | 0.520 |
Why?
|
| Channelopathies | 1 | 2016 | 11 | 0.520 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 715 | 0.490 |
Why?
|
| Myocardial Infarction | 2 | 2019 | 1000 | 0.480 |
Why?
|
| Humans | 49 | 2024 | 123169 | 0.480 |
Why?
|
| Epigenomics | 1 | 2015 | 162 | 0.470 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 1641 | 0.470 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2015 | 58 | 0.470 |
Why?
|
| Mice, Knockout | 16 | 2021 | 3718 | 0.470 |
Why?
|
| Action Potentials | 7 | 2021 | 500 | 0.470 |
Why?
|
| Patch-Clamp Techniques | 9 | 2018 | 277 | 0.460 |
Why?
|
| Gene Expression Regulation | 6 | 2013 | 2525 | 0.460 |
Why?
|
| Pyrazoles | 4 | 2010 | 303 | 0.450 |
Why?
|
| Biomarkers | 5 | 2024 | 2946 | 0.450 |
Why?
|
| Mice, Transgenic | 12 | 2022 | 2388 | 0.450 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 6 | 2018 | 37 | 0.440 |
Why?
|
| Electric Stimulation | 2 | 2012 | 319 | 0.430 |
Why?
|
| Physical Endurance | 1 | 2013 | 46 | 0.420 |
Why?
|
| Propanolamines | 1 | 2012 | 31 | 0.410 |
Why?
|
| Carbazoles | 1 | 2012 | 32 | 0.410 |
Why?
|
| Morpholines | 1 | 2012 | 56 | 0.400 |
Why?
|
| Long QT Syndrome | 2 | 2012 | 86 | 0.400 |
Why?
|
| RNA, Messenger | 4 | 2022 | 2813 | 0.400 |
Why?
|
| Endothelin Receptor Antagonists | 2 | 2010 | 14 | 0.400 |
Why?
|
| Physical Conditioning, Animal | 1 | 2013 | 91 | 0.390 |
Why?
|
| Exercise Test | 1 | 2013 | 249 | 0.390 |
Why?
|
| Obesity | 3 | 2023 | 2227 | 0.380 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2024 | 190 | 0.380 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2010 | 247 | 0.360 |
Why?
|
| Endothelins | 1 | 2010 | 8 | 0.350 |
Why?
|
| Receptor, Endothelin A | 3 | 2008 | 12 | 0.350 |
Why?
|
| Homeodomain Proteins | 3 | 2019 | 543 | 0.330 |
Why?
|
| Potassium Channels | 1 | 2010 | 158 | 0.320 |
Why?
|
| Phosphorylation | 11 | 2020 | 1608 | 0.320 |
Why?
|
| Vitamin E | 1 | 2008 | 64 | 0.300 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2007 | 46 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 10 | 2021 | 4346 | 0.290 |
Why?
|
| Mutation | 9 | 2024 | 5773 | 0.290 |
Why?
|
| Rats | 11 | 2015 | 3654 | 0.290 |
Why?
|
| Cells, Cultured | 8 | 2020 | 3042 | 0.280 |
Why?
|
| Hypertension, Pulmonary | 2 | 2008 | 430 | 0.270 |
Why?
|
| Ion Channels | 1 | 2007 | 188 | 0.270 |
Why?
|
| Cardiomyopathies | 3 | 2022 | 478 | 0.260 |
Why?
|
| Sodium-Calcium Exchanger | 3 | 2016 | 21 | 0.260 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 350 | 0.260 |
Why?
|
| Hypoxia | 2 | 2023 | 247 | 0.260 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 3084 | 0.250 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 2047 | 0.250 |
Why?
|
| Interleukin-1beta | 2 | 2023 | 159 | 0.250 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2018 | 63 | 0.240 |
Why?
|
| Membrane Potentials | 5 | 2013 | 304 | 0.240 |
Why?
|
| Cardiac Conduction System Disease | 1 | 2024 | 7 | 0.230 |
Why?
|
| Case-Control Studies | 4 | 2021 | 3249 | 0.230 |
Why?
|
| Aged | 11 | 2024 | 19080 | 0.230 |
Why?
|
| NFATC Transcription Factors | 2 | 2022 | 42 | 0.230 |
Why?
|
| Dioxygenases | 1 | 2024 | 46 | 0.230 |
Why?
|
| Gene Knock-In Techniques | 4 | 2019 | 122 | 0.220 |
Why?
|
| Glucosides | 1 | 2024 | 46 | 0.220 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2023 | 38 | 0.220 |
Why?
|
| Male | 25 | 2024 | 60082 | 0.220 |
Why?
|
| Benzhydryl Compounds | 1 | 2024 | 67 | 0.210 |
Why?
|
| Fibrosis | 3 | 2022 | 429 | 0.210 |
Why?
|
| Cytoplasm | 1 | 2024 | 289 | 0.210 |
Why?
|
| Transcription Factors | 3 | 2019 | 2585 | 0.200 |
Why?
|
| Heart Ventricles | 2 | 2018 | 759 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2010 | 1214 | 0.200 |
Why?
|
| Heat-Shock Proteins | 1 | 2023 | 194 | 0.200 |
Why?
|
| Calmodulin | 3 | 2017 | 228 | 0.190 |
Why?
|
| Cardiovascular Diseases | 3 | 2022 | 1863 | 0.190 |
Why?
|
| Folic Acid | 1 | 2024 | 292 | 0.190 |
Why?
|
| Molecular Targeted Therapy | 1 | 2024 | 353 | 0.190 |
Why?
|
| Adiposity | 1 | 2023 | 191 | 0.190 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2021 | 8 | 0.190 |
Why?
|
| Sheep, Domestic | 1 | 2021 | 17 | 0.190 |
Why?
|
| Ataxia | 1 | 2022 | 168 | 0.190 |
Why?
|
| Ankyrins | 2 | 2012 | 99 | 0.180 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 550 | 0.180 |
Why?
|
| Dependovirus | 2 | 2019 | 130 | 0.180 |
Why?
|
| Guinea Pigs | 3 | 2010 | 167 | 0.180 |
Why?
|
| DNA | 2 | 2017 | 1592 | 0.170 |
Why?
|
| Receptors, Thrombin | 1 | 2020 | 11 | 0.170 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2020 | 15 | 0.170 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2019 | 7 | 0.170 |
Why?
|
| Silk | 1 | 2019 | 3 | 0.170 |
Why?
|
| Up-Regulation | 4 | 2019 | 863 | 0.170 |
Why?
|
| Genetic Loci | 1 | 2021 | 333 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 530 | 0.160 |
Why?
|
| Repressor Proteins | 1 | 2024 | 810 | 0.160 |
Why?
|
| CRISPR-Cas Systems | 2 | 2019 | 251 | 0.160 |
Why?
|
| Natriuretic Peptide, C-Type | 1 | 2019 | 13 | 0.160 |
Why?
|
| Female | 20 | 2024 | 65500 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 1339 | 0.160 |
Why?
|
| Endothelin B Receptor Antagonists | 2 | 2008 | 4 | 0.160 |
Why?
|
| Endothelin A Receptor Antagonists | 2 | 2008 | 9 | 0.160 |
Why?
|
| Sorting Nexins | 1 | 2018 | 10 | 0.160 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2019 | 115 | 0.150 |
Why?
|
| Protein Phosphatase 1 | 2 | 2019 | 50 | 0.150 |
Why?
|
| Oxides | 1 | 2018 | 15 | 0.150 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 644 | 0.150 |
Why?
|
| Methylamines | 1 | 2018 | 17 | 0.150 |
Why?
|
| Sodium | 1 | 2019 | 291 | 0.150 |
Why?
|
| Protein Precursors | 1 | 2019 | 149 | 0.150 |
Why?
|
| Hypertension | 2 | 2021 | 1287 | 0.150 |
Why?
|
| Genetic Vectors | 2 | 2019 | 940 | 0.150 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 297 | 0.150 |
Why?
|
| Exercise | 1 | 2024 | 808 | 0.150 |
Why?
|
| Heart Arrest | 1 | 2022 | 340 | 0.150 |
Why?
|
| Risk Factors | 4 | 2021 | 10010 | 0.150 |
Why?
|
| Seizures | 1 | 2022 | 874 | 0.140 |
Why?
|
| Neutrophils | 1 | 2019 | 372 | 0.140 |
Why?
|
| 3' Untranslated Regions | 2 | 2014 | 165 | 0.140 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 357 | 0.140 |
Why?
|
| Thiazepines | 1 | 2016 | 8 | 0.140 |
Why?
|
| Antioxidants | 2 | 2010 | 338 | 0.130 |
Why?
|
| Aging | 2 | 2022 | 1174 | 0.130 |
Why?
|
| Gene Editing | 1 | 2018 | 187 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 1292 | 0.130 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 80 | 0.130 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 110 | 0.130 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2015 | 23 | 0.120 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2015 | 37 | 0.120 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2015 | 35 | 0.120 |
Why?
|
| Potassium | 1 | 2016 | 279 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 1683 | 0.120 |
Why?
|
| Sulfonamides | 3 | 2018 | 259 | 0.120 |
Why?
|
| Protein Conformation | 1 | 2016 | 834 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2015 | 231 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2018 | 678 | 0.110 |
Why?
|
| Blotting, Western | 3 | 2012 | 1100 | 0.110 |
Why?
|
| COUP Transcription Factor I | 1 | 2013 | 91 | 0.110 |
Why?
|
| Ear, Inner | 1 | 2013 | 52 | 0.110 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2013 | 12 | 0.110 |
Why?
|
| Cardiomegaly | 2 | 2012 | 133 | 0.100 |
Why?
|
| Apoptosis | 1 | 2019 | 1781 | 0.100 |
Why?
|
| Cytokines | 1 | 2018 | 1285 | 0.100 |
Why?
|
| Disease Progression | 3 | 2014 | 2025 | 0.100 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2013 | 92 | 0.100 |
Why?
|
| NADPH Oxidases | 2 | 2013 | 114 | 0.100 |
Why?
|
| Ventricular Fibrillation | 1 | 2012 | 51 | 0.100 |
Why?
|
| Electrocardiography | 4 | 2010 | 958 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 1099 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 849 | 0.100 |
Why?
|
| Ventricular Remodeling | 2 | 2012 | 174 | 0.090 |
Why?
|
| Middle Aged | 8 | 2024 | 25994 | 0.090 |
Why?
|
| Protein Subunits | 1 | 2011 | 164 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 351 | 0.090 |
Why?
|
| Time Factors | 4 | 2014 | 6217 | 0.090 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2008 | 137 | 0.090 |
Why?
|
| Calcium Channels | 1 | 2011 | 158 | 0.090 |
Why?
|
| Calcium Channel Blockers | 2 | 2008 | 113 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2019 | 1529 | 0.090 |
Why?
|
| Mice, Inbred mdx | 3 | 2018 | 40 | 0.090 |
Why?
|
| Molecular Structure | 2 | 2007 | 285 | 0.090 |
Why?
|
| Models, Animal | 1 | 2011 | 464 | 0.080 |
Why?
|
| Sudden Infant Death | 1 | 2009 | 33 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 160 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 1695 | 0.080 |
Why?
|
| Cornus | 1 | 2008 | 1 | 0.080 |
Why?
|
| Triterpenes | 1 | 2008 | 21 | 0.080 |
Why?
|
| Oxidation-Reduction | 3 | 2018 | 444 | 0.080 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2008 | 10 | 0.080 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2008 | 18 | 0.080 |
Why?
|
| Guanidines | 1 | 2008 | 25 | 0.080 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2008 | 10 | 0.080 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2008 | 13 | 0.080 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2008 | 37 | 0.080 |
Why?
|
| Stereoisomerism | 1 | 2008 | 103 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1682 | 0.070 |
Why?
|
| Phenethylamines | 1 | 2007 | 14 | 0.070 |
Why?
|
| Torsades de Pointes | 1 | 2007 | 6 | 0.070 |
Why?
|
| Vasoconstriction | 1 | 2007 | 104 | 0.070 |
Why?
|
| Epigenesis, Genetic | 2 | 2024 | 665 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 2008 | 196 | 0.070 |
Why?
|
| Age Factors | 1 | 2014 | 2802 | 0.070 |
Why?
|
| Naphthalenes | 1 | 2007 | 37 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 230 | 0.070 |
Why?
|
| Proteomics | 2 | 2021 | 479 | 0.070 |
Why?
|
| Oxidative Stress | 4 | 2018 | 796 | 0.070 |
Why?
|
| Myocardial Contraction | 3 | 2015 | 260 | 0.070 |
Why?
|
| Mice, Mutant Strains | 2 | 2017 | 381 | 0.060 |
Why?
|
| Reactive Oxygen Species | 3 | 2018 | 477 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2010 | 556 | 0.060 |
Why?
|
| Pulmonary Artery | 1 | 2008 | 439 | 0.060 |
Why?
|
| Aorta | 1 | 2007 | 541 | 0.060 |
Why?
|
| United Kingdom | 1 | 2024 | 191 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 793 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2008 | 519 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2015 | 312 | 0.050 |
Why?
|
| Echocardiography | 2 | 2024 | 1049 | 0.050 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2022 | 4 | 0.050 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2024 | 129 | 0.050 |
Why?
|
| Pericardium | 1 | 2023 | 82 | 0.050 |
Why?
|
| Troponin T | 1 | 2024 | 245 | 0.050 |
Why?
|
| Verapamil | 1 | 2022 | 52 | 0.050 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2022 | 58 | 0.050 |
Why?
|
| Magnesium | 1 | 2022 | 121 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2024 | 406 | 0.050 |
Why?
|
| Rabbits | 2 | 2016 | 708 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2016 | 12129 | 0.050 |
Why?
|
| Lung | 1 | 2008 | 1475 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2022 | 399 | 0.040 |
Why?
|
| Myocardial Ischemia | 2 | 2015 | 332 | 0.040 |
Why?
|
| Child | 4 | 2024 | 24237 | 0.040 |
Why?
|
| Dysbiosis | 1 | 2021 | 118 | 0.040 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2020 | 8 | 0.040 |
Why?
|
| Phenotype | 3 | 2018 | 4228 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2023 | 464 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2020 | 41 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2022 | 343 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2022 | 467 | 0.040 |
Why?
|
| Indenes | 1 | 2018 | 10 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 1687 | 0.040 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2019 | 52 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 233 | 0.040 |
Why?
|
| Receptor, Endothelin B | 2 | 2008 | 6 | 0.040 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2018 | 25 | 0.040 |
Why?
|
| Furans | 1 | 2018 | 27 | 0.040 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2009 | 114 | 0.040 |
Why?
|
| Sulfones | 1 | 2018 | 66 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2018 | 100 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2019 | 157 | 0.040 |
Why?
|
| Homeostasis | 1 | 2022 | 682 | 0.040 |
Why?
|
| NADPH Oxidase 2 | 1 | 2018 | 40 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 207 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 384 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 297 | 0.040 |
Why?
|
| Dogs | 1 | 2018 | 765 | 0.040 |
Why?
|
| Arteries | 1 | 2018 | 222 | 0.040 |
Why?
|
| Sheep | 1 | 2017 | 208 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 554 | 0.030 |
Why?
|
| RNA Interference | 1 | 2018 | 496 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1081 | 0.030 |
Why?
|
| Dantrolene | 1 | 2016 | 6 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 664 | 0.030 |
Why?
|
| Permeability | 1 | 2016 | 118 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 416 | 0.030 |
Why?
|
| Ion Channel Gating | 1 | 2016 | 123 | 0.030 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2015 | 14 | 0.030 |
Why?
|
| Hydroxylation | 1 | 2015 | 45 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2022 | 2306 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2020 | 878 | 0.030 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2015 | 37 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2771 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 98 | 0.030 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2013 | 3 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 863 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2014 | 112 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 69 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 6033 | 0.030 |
Why?
|
| Atrial Appendage | 1 | 2013 | 43 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2014 | 122 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 512 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2015 | 258 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 110 | 0.030 |
Why?
|
| Muscle Cells | 1 | 2012 | 24 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2014 | 389 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 2013 | 180 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2013 | 161 | 0.030 |
Why?
|
| Benzylamines | 1 | 2012 | 16 | 0.030 |
Why?
|
| Infant | 2 | 2022 | 12348 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 2012 | 87 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2012 | 46 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 276 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2012 | 43 | 0.020 |
Why?
|
| Protein Binding | 1 | 2016 | 1741 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 427 | 0.020 |
Why?
|
| Caffeine | 1 | 2012 | 71 | 0.020 |
Why?
|
| Serine | 1 | 2012 | 172 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 154 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2013 | 635 | 0.020 |
Why?
|
| Sarcolemma | 1 | 2010 | 24 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2010 | 41 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2010 | 48 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2012 | 214 | 0.020 |
Why?
|
| Protein Transport | 1 | 2011 | 369 | 0.020 |
Why?
|
| Death, Sudden | 1 | 2010 | 45 | 0.020 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2009 | 7 | 0.020 |
Why?
|
| Theophylline | 1 | 2009 | 29 | 0.020 |
Why?
|
| Adrenergic Agonists | 1 | 2009 | 11 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 354 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7148 | 0.020 |
Why?
|
| Cell Size | 1 | 2010 | 81 | 0.020 |
Why?
|
| Goats | 1 | 2009 | 55 | 0.020 |
Why?
|
| Calcineurin | 1 | 2010 | 100 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2012 | 766 | 0.020 |
Why?
|
| Streptozocin | 1 | 2008 | 24 | 0.020 |
Why?
|
| Monocrotaline | 1 | 2008 | 3 | 0.020 |
Why?
|
| Arterioles | 1 | 2008 | 28 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2008 | 39 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 661 | 0.020 |
Why?
|
| Nifedipine | 1 | 2008 | 21 | 0.020 |
Why?
|
| Epinephrine | 1 | 2009 | 175 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2012 | 494 | 0.020 |
Why?
|
| Muscle Relaxation | 1 | 2008 | 16 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2008 | 94 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 1114 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 522 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2008 | 135 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2008 | 186 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2012 | 1168 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 2025 | 0.020 |
Why?
|
| Methoxamine | 1 | 2007 | 2 | 0.020 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 2007 | 9 | 0.020 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2007 | 34 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2007 | 53 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2022 | 13887 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 2696 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2008 | 239 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 966 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 3868 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2009 | 991 | 0.020 |
Why?
|
| Peptides | 1 | 2009 | 794 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 3091 | 0.020 |
Why?
|
| Adolescent | 1 | 2022 | 19103 | 0.010 |
Why?
|
| Adult | 2 | 2012 | 29062 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3543 | 0.010 |
Why?
|
| Algorithms | 1 | 2007 | 1592 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 8863 | 0.010 |
Why?
|